Profile David Matthews

David Matthews, PhD

David Matthews, PhD, has 15 years of experience in pharmaceuticals, medical technology, and medical research.

Before joining BrightInsight, David was a Partner in the Healthcare, Commercial, and Corporate Finance & Strategy Practices at Boston Consulting Group (BCG), where he helped lead the West Coast Medical Technology business. He served a range of healthcare clients on strategy, commercial, R&D, medical & regulatory affairs, and transformation topics, including standing up medical SaaS businesses. He was selected as an Ambassador to BCG’s internal thinktank, the Henderson Institute, where he designed and published on new economic models for biopharma products, including building the Netflix model for curative therapies. While at the firm, he received several internal awards and recognition for thought leadership, apprenticeship, and client success.

Prior to his time at BCG, David was a computational neuroscientist, with more than 20 publications and conference proceedings across machine learning, bioinformatics, brain imaging, neuroanatomy, and health economics. He has consulted independently on machine learning applications in biomedicine, built an early telemedicine app for automated melanoma detection, and taught neuroscience as an Adjunct Professor.

David holds a PhD in Computational Neurobiology from The University of California, San Diego and the Salk Institute, where he was a National Science Foundation (NSF) Research Fellow and NSF Center for Theoretical Biological Physics Fellow; and a Bachelor with honors in Molecular Biology, and minors in Bioengineering and Neuroscience, from Princeton University.